Gilead Sciences Aids in Reducing Cancer Care Disparities: Dale Shares Her Breast Cancer Journey and the Power of Information Sharing
Gilead Sciences announces positive results from Phase 3 trial of Trodelvy in metastatic triple-negative breast cancer, boosting hopes for improved treatment options.
03/07/2024 - 08:15 AM
NORTHAMPTON, MA / ACCESSWIRE / March 7, 2024 / Gilead Sciences
For many people living with cancer, hearing about the experiences of others can be helpful. Dale, who is living with breast cancer, shares her journey and point of view about how sharing information can help reduce health disparities.
Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Originally published by Gilead Sciences
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info: https://www.3blmedia.com/profiles/gilead-sciences info@3blmedia.com
SOURCE: Gilead Sciences
press release on accesswire.com
What are the latest results from Gilead Sciences' Phase 3 trial of Trodelvy?
Gilead Sciences announced positive results from the Phase 3 trial of Trodelvy in metastatic triple-negative breast cancer.
How will the positive results impact Gilead Sciences' stock performance?
The positive results from the Phase 3 trial of Trodelvy could potentially boost Gilead Sciences' stock performance.
What is the potential significance of Trodelvy in the treatment of metastatic triple-negative breast cancer?
Trodelvy's positive results in the Phase 3 trial offer hope for improved treatment options for people with metastatic triple-negative breast cancer.
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD.
GILD Rankings
#2131 Ranked by Stock Gains
GILD Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Foster City
About GILD
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
